logo-loader

ANGLE PLC

Receive alerts
Market:
AIM
Market Cap:
£114.02 m
Price
66.00 GBX
Change
0.00%
52 weeks high
85.00
52 weeks low
38.00

In brief

ANGLE PLC develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease.

Deep dive We explore the investor case for growth companies

Snapshot

  • ANGLE is developing Parsortix blood test that can detect cancer
  • FDA submission underway after trial met objectives
  • Healthy cash balance
  • Other tests in development